Express report: pharmaceuticals
Ended Awarded Last action
- Contract number
- VA24617E6817
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $93,242
Award facts
- Contract value 100% obligated
- $93,241.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$11 | |
| Original award | $93,252 |
About this award
This federal contract award, valued at $93,241.75, was issued by the Veterans Integrated Service Network 6 (VISN 6), a component of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract is a Blanket Purchase Agreement (BPA) call under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows for the streamlined procurement of specialized pharmaceutical products. The contract is for the delivery of "EXPRESS REPORT: PHARMACEUTICALS" and does not have a set-aside designation, indicating Actelion Pharmaceuticals US, Inc. operates as a large business. The contract has a firm fixed-price pricing structure and a ultimate completion date of May 17, 2017. Actelion Pharmaceuticals US, Inc. is a for-profit pharmaceutical company that specializes in the development and distribution of medications for rare diseases, including pulmonary arterial hypertension, which are critical treatments for veterans and other eligible federal beneficiaries.
Quick answers
Who was awarded contract VA24617E6817?
VA24617E6817 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 5, 2017.
How much is contract VA24617E6817 worth?
The government has obligated $93,242 on VA24617E6817.
Is contract VA24617E6817 an order under another contract?
Yes. VA24617E6817 is a BPA call under V797P5160B-VA797P16A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA24617E6817 competed?
The extent of competition for VA24617E6817 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award